Your browser doesn't support javascript.
loading
Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial.
Kaabi, Nawal Al; Yang, Yun Kai; Liang, Yu; Xu, Ke; Zhang, Xue Feng; Kang, Yun; Jin, Yu Qin; Hou, Jun Wei; Zhang, Jing; Yang, Tian; Hussein, Salah; ElDein, Mohamed Saif; Lei, Ze Hua; Zhang, Hao; Shao, Shuai; Liu, Zhao Ming; Liu, Ning; Zheng, Xiang; Su, Ji Guo; Yang, Sen Sen; Cong, Xiangfeng; Tan, Yao; Lei, Wenwen; Gao, Xue Jun; Jiang, Zhiwei; Wang, Hui; Li, Meng; Mekki, Hanadi Mekki; Zaher, Walid; Mahmoud, Sally; Zhang, Xue; Qu, Chang; Liu, Dan Ying; Zhang, Jing; Yang, Mengjie; Eltantawy, Islam; Xiao, Peng; Shen, Fu Jie; Wu, Jin Juan; Han, Zi Bo; Du, Li Fang; Tang, Fang; Chen, Shi; Ma, Zhi Jing; Zheng, Fan; Hou, Ya Nan; Li, Xin Yu; Li, Xin; Wang, Zhao Nian; Yin, Jin Liang.
Affiliation
  • Kaabi NA; Sheikh Khalifa Medical City, SEHA, Abu Dhabi, UAE.
  • Yang YK; College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, UAE.
  • Liang Y; China National Biotec Group Company Limited, Beijing, China.
  • Xu K; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.
  • Zhang XF; National Engineering Center for New Vaccine Research, Beijing, China.
  • Kang Y; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China.
  • Jin YQ; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.
  • Hou JW; National Engineering Center for New Vaccine Research, Beijing, China.
  • Zhang J; National Engineering Center for New Vaccine Research, Beijing, China.
  • Yang T; Clinical Medicine Office, National Vaccine and Serum Institute (NVSI), Beijing, China.
  • Hussein S; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.
  • ElDein MS; National Engineering Center for New Vaccine Research, Beijing, China.
  • Lei ZH; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.
  • Zhang H; National Engineering Center for New Vaccine Research, Beijing, China.
  • Shao S; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.
  • Liu ZM; National Engineering Center for New Vaccine Research, Beijing, China.
  • Liu N; China National Biotec Group Company Limited, Beijing, China.
  • Zheng X; Sheikh Khalifa Medical City, SEHA, Abu Dhabi, UAE.
  • Su JG; Sheikh Khalifa Medical City, SEHA, Abu Dhabi, UAE.
  • Yang SS; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.
  • Cong X; National Engineering Center for New Vaccine Research, Beijing, China.
  • Tan Y; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.
  • Lei W; National Engineering Center for New Vaccine Research, Beijing, China.
  • Gao XJ; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.
  • Jiang Z; National Engineering Center for New Vaccine Research, Beijing, China.
  • Wang H; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.
  • Li M; National Engineering Center for New Vaccine Research, Beijing, China.
  • Mekki HM; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.
  • Zaher W; National Engineering Center for New Vaccine Research, Beijing, China.
  • Mahmoud S; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.
  • Zhang X; National Engineering Center for New Vaccine Research, Beijing, China.
  • Qu C; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.
  • Liu DY; National Engineering Center for New Vaccine Research, Beijing, China.
  • Zhang J; National Engineering Center for New Vaccine Research, Beijing, China.
  • Yang M; Clinical Medicine Office, National Vaccine and Serum Institute (NVSI), Beijing, China.
  • Eltantawy I; National Engineering Center for New Vaccine Research, Beijing, China.
  • Xiao P; Clinical Medicine Office, National Vaccine and Serum Institute (NVSI), Beijing, China.
  • Shen FJ; National Engineering Center for New Vaccine Research, Beijing, China.
  • Wu JJ; Clinical Medicine Office, National Vaccine and Serum Institute (NVSI), Beijing, China.
  • Han ZB; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China.
  • Du LF; Lanzhou Institute of Biological Products Company Limited, Lanzhou, China.
  • Tang F; Beijing Key Tech Statistical Consulting Co., Ltd, Beijing, China.
  • Chen S; Beijing Institute of Biological Products Company Limited, Beijing, China.
  • Ma ZJ; China National Biotec Group Company Limited, Beijing, China.
  • Zheng F; Union 71, Abu Dhabi, UAE.
  • Hou YN; G42 Healthcare, Abu Dhabi, UAE.
  • Li XY; G42 Healthcare, Abu Dhabi, UAE.
  • Li X; China National Biotec Group Company Limited, Beijing, China.
  • Wang ZN; China National Biotec Group Company Limited, Beijing, China.
  • Yin JL; China National Biotec Group Company Limited, Beijing, China.
Signal Transduct Target Ther ; 8(1): 20, 2023 01 03.
Article in En | MEDLINE | ID: mdl-36596779
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Clinical_trials Limits: Adult / Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Clinical_trials Limits: Adult / Humans Language: En Year: 2023 Type: Article